Giacomo Novara is an expert in Urology at University of Padua (Italy). Giacomo Novara has authored 552 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,620 (community average: 125). How the SLR is computed.

LeadR Profile

Giacomo Novara University of Padua Italy
1 620 ScienceLeadR Reputation 1620
Network Map

Urology

Subspecialties: Oncology - Surgery - Histology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2005 - 2026

Source: PubMed

University of Padua

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 552

Citations

Citations: 28 571 1st author: 85 Last author: 60 Unique author: 15


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The PROTEUS trial: envisioning the future of perioperative therapy and radical prostatectomy for high-risk prostate cancer. Official position of the Italian Society of Urology (SIU).
PMID 42545136 — urology, proteus, neoplasms, prostate, prostatic neoplasms, therapeutics, prostatectomy
Minerva Urol Nephrol20260
The utility of pelvic lymph node dissection in PSMA-PET negative intermediate and high-risk prostate cancer patients undergoing radical prostatectomy.
PMID 41814009 — urology, lymph nodes, neoplasms, propensity score, prostate, lymph, prostatic neoplasms, prostatectomy, dissection
World J Urol20260
New prospective of omitting pelvic lymph node dissection during radical prostatectomy for prostate cancer patients with negative preoperative PSMA PET.
PMID 40891475 — urology, lymph nodes, neoplasms, prostate, lymph, prostatic neoplasms, prostatectomy, dissection
Minerva Urol Nephrol20250
Detection Rates of Prostate Cancer Across Prostatic Zones Using Freehand Single-Access Transperineal Fusion Biopsies.
PMID 40647504 — neoplasms, prostate, biopsy, prostatic neoplasms
Cancers (Basel)20250
Follow-up on patients with initial negative mpMRI target and systematic biopsy for PI-RADS ≥ 3 lesions - an EAU-YAU study enhancing prostate cancer detection.
PMID 39501078 — multiparametric magnetic resonance imaging, neoplasms, prostate, biopsy, prostatic neoplasms, wounds and injuries
Prostate Cancer Prostatic Dis20242

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 3

LeadR Networks

Main global connection map